Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
+870K
-
Total reported value, excl. options
-
$1.27B
-
Value change
-
+$27M
-
Put/Call ratio
-
1.51
-
Number of buys
-
65
-
Number of sells
-
-75
-
Price
-
$23.22
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2023
166 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q2 2023.
Replimune Group, Inc. - COMMON STOCK (REPL) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
of 78.4M outstanding shares and own 69.64% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.73M shares), BAKER BROS. ADVISORS LP (4.58M shares), Redmile Group, LLC (4.42M shares), BlackRock Inc. (3.49M shares), Omega Fund Management, LLC (3M shares), VANGUARD GROUP INC (2.35M shares), BVF INC/IL (2.14M shares), Atlas Venture Life Science Advisors, LLC (2.1M shares), STATE STREET CORP (2.09M shares), and Camber Capital Management LP (1.55M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.